Two AstraZeneca whistleblowers share $1.4 million in FCA settlement
Pharma AstraZeneca LP agreed to pay $7.9 million to settle allegations that it violated the False Claims Act by paying kickbacks to sell its drugs, the DOJ said.
AstraZeneca markets and sells pharmaceutical products in the United States, including a drug sold under the trade name Nexium.… Continue Reading